Is Haleon plc (HLN) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 22.1% / 30% | 4.8% / 30% | 3.5% / 30% | N/A | ✓ HALAL |
| DJIM | 22.1% / 33% | 4.8% / 33% | 3.5% / 33% | N/A | ✓ HALAL |
| MSCI | 29.4% / 33% | 6.4% / 33% | 4.6% / 33% | N/A | ✓ HALAL |
| S&P | 22.1% / 33% | 4.8% / 33% | 3.5% / 33% | N/A | ✓ HALAL |
| FTSE | 29.4% / 33% | 6.4% / 33% | 4.6% / 50% | N/A | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 64.8% | |
| Operating Margin | 23.2% | |
| Net Margin | 15.1% | |
| Return on Equity (ROE) | 10.3% | |
| Return on Assets (ROA) | 4.7% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $2.6B |
| Free Cash Flow | $2.2B |
| Total Debt | $8.6B |
| Debt-to-Equity | 52.4 |
| Current Ratio | 0.9 |
| Total Assets | $32.6B |
Price & Trading
| Last Close | $9.75 |
| 50-Day MA | $10.49 |
| 200-Day MA | $9.88 |
| Avg Volume | 8.2M |
| Beta | 0.2 |
|
52-Week Range
$8.71
| |
About Haleon plc (HLN)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Haleon plc (HLN) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Haleon plc is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Haleon plc's debt ratio?
Haleon plc's debt ratio is 22.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 29.4%.
What are Haleon plc's key financial metrics?
Haleon plc has a market capitalization of $43.7B, trailing P/E ratio of 20.0, and revenue of $11.0B. The company maintains a gross margin of 64.8% and a net margin of 15.1%. Return on equity stands at 10.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.